Recordati Rare Diseases North America

Recordati Rare Diseases Inc. (RRD) markets products to treat rare diseases. RRD is a member of the Recordati Group, which includes Recordati S.p.A., Orphan Europe, among other companies around the globe. The Recordati Group, which was established in 1926 currently employs more than 4,000 worldwide. The RRD mission is to reduce the impact of extremely rare and devastating diseases by providing urgently needed therapies. We work side-by-side with rare disease communities to increase awareness, improve diagnosis and expand availability of treatments for people with rare diseases

Rare diseases and orphan drugs

Recordati rare diseases north america operates in the Pharmaceutical manufacturing industry.

Recordati rare diseases north america's revenue is 11m - 100m

Recordati rare diseases north america has 201 - 500 employees.